Home › Ironwood borrows $175M to fund IBS drug launch
 

Keywords :   


Ironwood borrows $175M to fund IBS drug launch

2013-01-05 13:00:31| Biotech - Topix.net

Ironwood Pharmaceuticals , Inc. has completed a $175 million debt offering to support the launch of its newly approved drug for irritable bowel syndrome , Linzess.

Tags: drug fund launch ibs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.10Hurricane Milton Public Advisory Number 11A
08.10Summary for Hurricane Milton (AT4/AL142024)
08.10Eastern North Pacific Tropical Weather Outlook
08.10Atlantic Tropical Weather Outlook
08.10Wait longer for an electric taxi, says Uber boss
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Customers of failed crypto firm FTX set for refunds
07.10Hurricane Milton Graphics
More »